Filing Details
- Accession Number:
- 0001683168-23-005202
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-01 19:29:37
- Reporting Period:
- 2023-07-30
- Accepted Time:
- 2023-08-01 19:29:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1817685 | Stewart Nicholas Green | 14191 Myford Road Tustin CA 92780 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2023-07-30 | 37,500 | $0.00 | 165,363 | No | 4 | M | Direct | |
Common Stock, $0.001 Par Value | Disposition | 2023-07-31 | 19,519 | $12.99 | 145,844 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2023-07-30 | 37,500 | $0.00 | 37,500 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
323,647 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnote 4. This sale does not represent a discretionary trade by the reporting person.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $12.9648 to $12.99. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- RSUs granted to the reporting person on July 30, 2020, vest in four (4) equal annual installments beginning July 30, 2021, and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.